The committee voted to lower the recommended age for MSD’s Capvaxive and Pfizer’s Prevnar 20 to 50 years down from 65.

The company will use the funds to advance its pipeline of cancer-targeting preclinical candidates to the “clinic-ready” stage ...

Experimental new therapies, regulatory changes, sustainability imperatives – biomanufacturers are navigating a changing ...

Novo Nordisk has asked the FDA to add semaglutide to a list that would effectively block manufacturing of copycat versions of ...

Nitrosamines are organic compounds that have gained attention in the pharma industry as impurities in manufacturing.

The opioid addiction treatment market will be worth $2.4bn by 2033, driven by diagnoses in the eight major world markets.

At CPHI Europe, an expert discussed the significance of implementing effective AI strategies to improve nutraceutical ...

ICON Specialty Laboratory Solutions has created a new, advanced test using next-generation sequencing (NGS) technology. Based ...

Be Biopharma has raised $82m in financing to advance a gene therapy targeting hemophilia B to a Phase I/II trial, whilst also ...

TreeFrog has entered a research collaboration with the University of Pittsburgh to investigate the role of TLS in ...

Conflict in Gaza, Sudan and Yemen have complicated polio vaccination efforts, and the GPEI now expects eradication to take ...

The UK’s National Institute of Health and Care Excellence (NICE) said the drug provided only a small benefit to patients.